drug

Neuronavigated Intermittent Theta Burst Stimulation

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Douglas Mental Health University Institute
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
NCT07428460—Recruiting

KOLs & investigators

4
Lena Palaniyappan, MD, PhDKOL score 10
Stéphane Potvin, PhDKOL score 8
David Benrimoh, MD.CM., MSc., MSc., FRCPC
Olivier Roy, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Douglas Mental Health University Institute
company
trial
Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia and Predominant Negative Symptoms
indication
KOL
Lena Palaniyappan, MD, PhD
KOL score 10
person
Stéphane Potvin, PhD
KOL score 8
person
David Benrimoh, MD.CM., MSc., MSc., FRCPC
KOL score —
person
Olivier Roy, MD
KOL score —
person